Invention Application
- Patent Title: TISSUE ANCHORING ARTICLES
-
Application No.: US17530585Application Date: 2021-11-19
-
Publication No.: US20220151940A1Publication Date: 2022-05-19
- Inventor: Carlo Giovanni Traverso , Alex G. Abramson , Ester Caffarel Salvador , Niclas Roxhed , Minsoo Khang , Taylor Bensel , David Dellal , Robert S. Langer
- Applicant: Massachusetts Institute of Technology , The Brigham and Women's Hospital, Inc.
- Applicant Address: US MA Cambridge; US MA Boston
- Assignee: Massachusetts Institute of Technology,The Brigham and Women's Hospital, Inc.
- Current Assignee: Massachusetts Institute of Technology,The Brigham and Women's Hospital, Inc.
- Current Assignee Address: US MA Cambridge; US MA Boston
- Main IPC: A61K9/48
- IPC: A61K9/48 ; A61J3/07 ; A61K9/00 ; A61B5/145 ; A61B10/02 ; A61M5/142 ; A61M37/00 ; A61N1/32 ; A61N1/36 ; A61M5/20 ; A61M5/32 ; A61M31/00 ; A61K38/28 ; A61M5/158

Abstract:
Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surface (e.g., a surface of a tissue of a subject). The self-righting articles described herein may comprise one or more tissue engaging surfaces configured to engage (e.g., interface with, inject into, anchor) with a surface (e.g., a surface of a tissue of a subject). In some embodiments, the self-righting article may have a particular shape and/or distribution of density (or mass) which, for example, enables the self-righting behavior of the article. In some embodiments, the self-righting article may comprise a tissue interfacing component and/or a pharmaceutical agent (e.g., for delivery of the active pharmaceutical agent to a location internal of the subject). In some cases, upon contact of the tissue with the tissue engaging surface of the article, the self-righting article may be configured to release one or more tissue interfacing components. In some cases, the tissue interfacing component is associated with a self-actuating component. For example, the self-righting article may comprise a self-actuating component configured, upon exposure to a fluid, to release the tissue interfacing component from the self-righting article. In some cases, the tissue interfacing component may comprise and/or be associated with the pharmaceutical agent (e.g., for delivery to a location internal to a subject).
Information query